Global Opportunities in Cerebral Embolization Markets

Posted by Life Science Intelligence on Jan 7, 2020 7:04:12 PM
Find me on:

Stroke is the second largest cause of death globally, claiming an estimated 5.5 million lives annually. The burden of stroke is expected to worsen in the future as a result of demographic and lifestyle changes in developed and developing countries. During the acute stage there are several pharmaceuticals and surgical procedures available to assist healthcare providers manage stroke patients. This market research report provides forecasts and analysis of the embolization products used in the management and treatment of stroke. In addition to market forecasts, this report provides insights into the leading competitors in the cerebral embolization products market.

Cerebral Embolization Products for Stroke - Quick Market Summary

Estimated market value in 2019

$1.9 Billion

Types of Cerebral Embolization Products

SAH treatment; Management of cerebral aneurysms; Management of AVMs

Product Types

Coils; Liquid embolic agents; Stent-assisted coils; Flow diverters

Largest geographic market

United States

Market leaders

Medtronic, Stryker, Terumo

Notes: SAH = subarachnoid hemorrhage. AVM = arteriovenous malformation.

According to a new report from LSI's Medtech Pro Platform, Global Opportunities in Cerebral Embolization Markets, global sales of cerebral embolization products for the treatment of stroke were estimated to total $1.9bn in 2019. During the forecast period covered by this analysis, sales attributable to cerebral embolization products will increase at a compound annual growth rate (CAGR) of 8.0%, reaching $2.6bn by 2023. Embolization products for the treatment of subarachnoid hemorrhage and cerebral aneurysm were estimated to account for the majority (~74%) of global cerebral embolization product sales in 2019 – a trend that is projected to persist throughout the forecast period. By product type, embolization coils accounted for the largest share of total product sales.

By geography, the US is the largest market in terms of total cerebral embolization product sales and will continue to account for the greatest share of total product sales throughout the forecast period covered by this analysis. LSI estimates that the US accounted for approximately 39% of global sales in 2019 – a trend that is projected to persist throughout the forecast.

Market leaders in cerebral embolization products market include Medtronic, Stryker, and Terumo Interventional Systems. Together these companies accounted for ~74% of global sales in 2018. Other competitors offering cerebral embolization products for the treatment of stroke covered by this report include Johnson & Johnson, Balt, and Penumbra, among others.

Visit LSI to learn to view the report and learn more about how cerebral embolization devices transforming the management and treatment of stroke.

Topics: Insider, Startup, Strategics, Medtech, Medtech Venture Capital, Surgical Procedure Volumes

Stay connected with our latest posts:

About the Author

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.

Contact LSI here, via phone 714 847 3540, or email info@lsintel.com